Stock Price
115.88
Daily Change
0.83 0.72%
Monthly
-3.81%
Yearly
46.41%
Q3 Forecast
114.10

Gilead Sciences reported $15.39 in PE Price to Earnings for its fiscal quarter ending in June of 2025.




Pe Change Date
AbbVie USD 18.41 69.26 Jun/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
ALKERMES USD 13.78 1.23 Jun/2025
Amgen USD 12.51 28.7 Jun/2025
Biogen USD 12.41 0.17 Jun/2025
BioMarin Pharmaceutical USD 15.13 7.26 Jun/2025
Bristol-Myers Squibb USD 17.27 3.22 Jun/2025
Eli Lilly USD 37 7.55 Jun/2025
Gilead Sciences USD 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Glaxosmithkline GBP 18.39 3.81 Jun/2025
Incyte USD 14.77 134.3 Jun/2025
J&J USD 19.02 9.62 Jun/2025
Merck USD 8.58 4.74 Jun/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 42.61 5.9 Jun/2025
Novartis USD 15.89 3.03 Jun/2025
Pfizer USD 9.12 8.86 Jun/2025
PTC Therapeutics USD 6.47 0.7 Jun/2025
Regeneron Pharmaceuticals USD 13.35 3.19 Jun/2025
Sanofi EUR 16.47 6.85 Jun/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
United Therapeutics USD 11.45 0.02 Jun/2025
Vertex Pharmaceuticals USD 27.81 3.5 Jun/2025